STOCK TITAN

VERA (NASDAQ: VERA) affiliate files Form 144 to sell 18,500 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

VERA affiliate notified a proposed sale of 18,500 shares through a Form 144 filing.

The filing states 18,500 common shares are to be sold on 05/12/2026 following an exercise of stock options for cash. The excerpt also lists prior 10b5-1 sales by Marshall Fordyce: 22,951 shares on 04/14/2026 and 16,925 shares on 02/23/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies a planned resale of 18,500 shares tied to option exercise.

The filing lists an exercise of stock options with sale method labeled as cash on 05/12/2026. This form is a regulatory notice required for affiliate resales when certain conditions are met.

Cash‑flow treatment is stated as cash for the immediate sale; preceding 10b5-1 sales on 04/14/2026 and 02/23/2026 are shown as historical dispositions. Subsequent public filings may disclose completion details.

Proposed shares to sell 18,500 shares proposed sale tied to option exercise on 05/12/2026
Prior 10b5-1 sale (Apr) 22,951 shares 10b5-1 sale on 04/14/2026 by Marshall Fordyce
Prior 10b5-1 sale (Feb) 16,925 shares 10b5-1 sale on 02/23/2026 by Marshall Fordyce
Proceeds reported (Apr sale) $1,011,050.49 aggregate proceeds for 22,951 shares on 04/14/2026
Proceeds reported (Feb sale) $710,577.51 aggregate proceeds for 16,925 shares on 02/23/2026
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"10b5-1 Sales for MARSHALL FORDYCE"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
exercise of stock options financial
"Exercise of Stock Options | Issuer"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does VERA's Form 144 disclose about the 05/12/2026 sale?

It discloses a proposed sale of 18,500 common shares tied to an exercise of stock options with proceeds described as cash. The filing lists the intended sale date as 05/12/2026 and identifies the sale method as option exercise and cash disposition.

Who reported the prior 10b5-1 sales shown in the Form 144 for VERA?

The filing lists prior 10b5-1 sales attributed to Marshall Fordyce. It shows 22,951 shares sold on 04/14/2026 and 16,925 shares sold on 02/23/2026, with aggregate proceeds noted for each transaction.

Does the Form 144 state how proceeds will be used for the VERA sale?

The excerpt states the securities are sold following an exercise of stock options and lists the payment method as cash. The filing does not include a use‑of‑proceeds allocation or additional disposition instructions in the provided excerpt.

Is the 18,500‑share amount in the Form 144 an executed sale or a proposed resale?

The Form 144 provides notice of a proposed resale of 18,500 shares associated with an option exercise and lists the intended sale date 05/12/2026. Completion status and transaction settlement details are not included in the excerpt.